Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.995 USD | +5.56% | -1.48% | +1.01% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.01% | 169M | |
+3.33% | 42.11B | |
+48.83% | 40.08B | |
+8.46% | 40B | |
-10.82% | 26.87B | |
+8.20% | 24.58B | |
-23.82% | 18.44B | |
+2.11% | 11.94B | |
+33.39% | 11.66B | |
+7.47% | 11.01B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701 with Opdivo® and Bristol Myers Squibb's Anti-TIGIT Antibody, BMS-986207